Articles published in Journal of Pharmacogenomics & Pharmacoproteomics have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacogenomics & Pharmacoproteomics has got h-index 12, which means every article in Journal of Pharmacogenomics & Pharmacoproteomics has got 12 average citations.
Following are the list of articles that have cited the articles published in Journal of Pharmacogenomics & Pharmacoproteomics.
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Year wise published articles |
30 | 30 | 13 | 4 | 7 |
Year wise citations received |
59 | 69 | 60 | 48 | 62 |
Journal total citations count | 548 |
Journal Impact Factor | 2.31 |
Journal 5 years Impact Factor | 3.74 |
Journal CiteScore | 4.86 |
Journal h-index | 12 |
Duconge, Jorge. "Why admixture matters in genetically-guided therapy: Missed targets in the COAG and EU-PACT trials." Puerto Rico health sciences journal 34.3 (2015): 175.
Claudio-Campos, Karla, et al. "Pharmacogenetics of drug-metabolizing enzymes in US Hispanics." Drug metabolism and personalized therapy 30.2 (2015): 87-105.
Orengo-Mercado, Carmelo, et al. "Frequencies of functional polymorphisms in three pharmacokinetic genes of clinical interest within the admixed Puerto Rican population." Journal of pharmacogenomics & pharmacoproteomics 4.113 (2013).
Arias, Albert J., and R. Andrew Sewell. "Pharmacogenetically driven treatments for alcoholism." CNS drugs 26.6 (2012): 461-476.
Nishant, T., et al. "Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases." J Pharmacogenomics Pharmacoproteomics 2 (2011): 107.
Shimoyama, Shouji. "Chemotherapy for Gastric Cancer—What Comes Next?." Updates on Cancer Treatment. InTech, 2015.
Praveenya, P., et al. "Antibiotic Resistance Creating New Epoch." J Bacteriol Parasitol 3.131 (2012): 2.
Naga Anusha, P., A. Siddiqui, and A. Hima Bindu. "Immuno Defense Mechanism against Tumors." J Cancer Sci Ther S 17 (2011): 2.
Nishant, T., et al. "Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases." J Pharmacogenomics Pharmacoproteomics 2 (2011): 107.76.pdf
Sultana, Shabana. "Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences."
Eckstein, Lisa. "Searching for a role for genomics in the right to health." Advancing the Human Right to Health (2013): 391.
Bushyakanist, Asalaysa, et al. "The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand." Pharmacogenomics and personalized medicine 8 (2015): 163.
Plumpton, Catrin O., et al. "A systematic review of economic evaluations of pharmacogenetic testing for prevention of adverse drug reactions." PharmacoEconomics 34.8 (2016): 771-793.
Zuniga, José M., Stephen P. Marks, and Lawrence O. Gostin, eds. Advancing the human right to health. OUP Oxford, 2013.
Rattanavipapong, Waranya, et al. "Economic evaluation of HLAâ€B* 15: 02 screening for carbamazepineâ€induced severe adverse drug reactions in Thailand." Epilepsia 54.9 (2013): 1628-1638.
Nishant, T., et al. "Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases." J Pharmacogenomics Pharmacoproteomics 2 (2011): 107.
Dalal, Bhavik, Aruna Shankarkumar, and K. Ghosh. "Individualization of antiretroviral therapy-Pharmacogenomic aspect." The Indian journal of medical research 142.6 (2015): 663.
Martin, Jennifer H., et al. "Insulin Analogues: Reviewing the Pros and Cons in Managing Diabetes Mellitus." J Pharmacogenom Pharmacoproteomics 2.106 (2011): 2153-0645.
Sultana, Shabana. "Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences."
Kumar, Anand, Archna Nagpal, and Puneeta Vohra. "Personalized medicine: A step forward in dental treatment." Journal of Indian Academy of Oral Medicine and Radiology 27.1 (2015): 76.